|
Post by lakers on Jun 5, 2017 14:42:02 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 5, 2017 15:52:54 GMT -5
So before everyone goes nuts (and how many times have I mentioned this but it falls on def ears) CHUMP CHANGE TO THESE GUYS
Initiates MannKind
Mintz initiated a new position in the biopharma MannKind with the purchase of 209,292 shares valued at $310,000. This is about 0.01% of the fund’s total portfolio holdings. California-based MannKind, find, develops and sells therapeutic products for patients with diseases such as diabetes.
|
|
|
Post by n8 on Jun 5, 2017 16:39:23 GMT -5
Still an indicator that awareness is growing.
|
|
|
Post by agedhippie on Jun 5, 2017 18:10:11 GMT -5
Still an indicator that awareness is growing. The funds specialize in volatility so that was more likely a play on volatility around the reverse split. They will have done splendidly from it!
|
|